Nanologica AB (publ) (FRA:4YD)

Germany · Delayed Price · Currency is EUR

0.0350

0.00 (0.00%)

Last updated: Feb 23, 2026, 8:21 AM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Chroma	1.56M	1.91M	4.47M
Chroma Growth	-18.63%	-57.21%	-9.49%
Drug Development - DD	-	10.36M	11.67M
Drug Development - DD Growth	-	-11.21%	171.81%
Unallocated Business Support	-	642.00K	-
Total	1.56M	12.91M	16.14M
Total Growth	-87.96%	-19.96%	74.87%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	8.43M	654.00K	699.00K	1.31M	3.32M
China Growth	1188.38%	-6.44%	-46.60%	-60.62%	-30.47%
India	5.92M	188.00K	128.00K	-	-
India Growth	3046.81%	46.88%	-	-	-
United States of America (USA)	21.00K	-	276.00K	103.00K	410.00K
United States of America (USA) Growth	-	-	167.96%	-74.88%	3316.67%
Rest of The World	175.00K	601.00K	452.00K	1.92M	2.37M
Rest of The World Growth	-70.88%	32.96%	-76.41%	-18.99%	1577.30%
Sweden	-	-	-	9.24M	10.04M
Sweden Growth	-	-	-	-7.90%	133.78%
Turkey	-	-	-	343.00K	-
Total	14.54M	1.44M	1.56M	12.91M	16.14M
Total Growth	907.48%	-7.20%	-87.96%	-19.96%	74.87%

Source: S&P Global Market Intelligence.